Director, Investigational Drug Service
Cleveland Clinic
John Petrich MS RPh is the Director of Pharmacy and the Residency Program Director at the Cleveland Clinic for Investigational Drugs and Research. His team supports a wide variety of clinical trials across a growing international landscape. John assists investigators with protocol development and execution, while maintaining a focus on rational drug utilization, regulatory compliance, quality improvement, and biosafety awareness throughout the enterprise.
With the emergence of gene therapies, John has helped champion the effort to enrich guidances around safe handling, site preparedness, and risk evaluation for hospitals and health systems. His recent work has sought to provide much-needed direction to site pharmacies on gene therapy management. John recently authored a review in The Journal of Pharmacy Practice titled Gene Replacement Therapy: A Primer for the Health-system Pharmacist and he has presented extensively on the topic of gene therapy.
John received his Pharmacy degree from the University of Toledo and his Master’s degree from Cleveland State University. He is a long-standing presenter for the American Society of Health-System Pharmacists (ASHP), and past president of the Society of Clinical Research Associates (SOCRA).
Update on Gene Therapies and Immune-Based Chemotherapy
Tuesday, December 5, 2023
4:00 PM – 5:00 PM